Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parkinson's Disease

  Free Subscription


Articles published in Biol Psychiatry

Retrieve available abstracts of 6 articles:
HTML format
Text format



Single Articles


    December 2018
  1. SU Y, Deng MF, Xiong W, Xie AJ, et al
    MicroRNA-26a/Death-Associated Protein Kinase 1 Signaling Induces Synucleinopathy and Dopaminergic Neuron Degeneration in Parkinson's Disease.
    Biol Psychiatry. 2018 Dec 19. pii: S0006-3223(18)32086.
    PubMed     Text format     Abstract available


    December 2016
  2. SCANGOS KW, Shahlaie K
    Acute Frequency-Dependent Hypomania Induced by Ventral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Case Report.
    Biol Psychiatry. 2016 Dec 7. pii: S0006-3223(16)33058.
    PubMed     Text format    


    March 2016
  3. TOZZI A, de Iure A, Bagetta V, Tantucci M, et al
    Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit.
    Biol Psychiatry. 2016;79:402-14.
    PubMed     Text format     Abstract available


  4. BASTIDE MF, de la Crompe B, Doudnikoff E, Fernagut PO, et al
    Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia.
    Biol Psychiatry. 2016;79:345-53.
    PubMed     Text format     Abstract available


  5. FEYDER M, Sodersten E, Santini E, Vialou V, et al
    A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and FosB Expression.
    Biol Psychiatry. 2016;79:362-71.
    PubMed     Text format     Abstract available


  6. ENGELN M, Bastide MF, Toulme E, Dehay B, et al
    Selective Inactivation of Striatal FosB/DeltaFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.
    Biol Psychiatry. 2016;79:354-61.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: